Offline 
Background
Location:
Las Vegas, Nevada
United States
Las Vegas, Nevada
United States
Work:
AARP State Office-Serving Nevadans statwide through information, advocacy, education, and community service
AARP State Office-Serving Nevadans statwide through information, advocacy, education, and community service
Quote:
"What we do we do for all." Ethel Percy Andrus, Founder
"What we do we do for all." Ethel Percy Andrus, Founder
AARP Research Focuses on Brand Name Rx Costs
FOR IMMEDIATE RELEASE
March 5, 2008
AARP Report Finds Brand Name Drug Prices Continue to Soar
New Rx drug brochure for Nevadans may help some with costs
Las Vegas, Nevada – According to a report released today by AARP, pharmaceutical companies have substantially raised prices on 220 brand name prescription drugs most commonly used by people in Medicare Part D since the implementation of the drug benefit in 2006.
AARP has studied drug prices since 2002 and reported the findings in a series of Watchdog reports. Today’s report expands on the series by focusing its analysis on those brand prescription drugs most widely used by people enrolled in Medicare Part D.
The Watchdog report, which was produced by AARP’s Public Policy Institute (PPI), found that prices of brand name drugs most commonly used by people in Medicare Part D rose by an average of 7.4 percent in 2007 – nearly two and a half times the rate of general inflation. The report concludes that rising prices threaten consumers by increasing the likelihood of higher insurance premiums and the chance that people will fall into the Medicare coverage gap, and increasing the out-of-pocket expenses of those who find themselves in this “donut hole.”
“Medicare Part D is helping millions of people afford their prescription drugs, but as brand name drug costs continue to soar more needs to be done to keep drugs affordable,” said John Rother, AARP Director of Public Policy. “The Medicare Part D benefit helps more people afford their prescription drugs. But we must make greater progress in putting downward pressure on drug prices."
The average treatment cost exploded from $80 per year per prescription in 2002, to $151 in 2007. A person who took three brand name prescriptions to treat a chronic condition over this period saw an increase in their yearly costs of more than $1,600 between 2002 and 2007. The study found brand name drug prices increased far greater than general inflation since 2002, with dramatic spikes since 2006, the period when Medicare Part D was implemented.
“This report raises questions about why the pharmaceutical companies so dramatically increased the costs of popular brand name drugs at the same time Medicare began offering drug coverage,” added Rother. “When pharmaceutical companies raise wholesale prices, consumers are ultimately stuck with the bill.”
“In the meantime, our elected leaders need to find sustainable solutions to the skyrocketing costs of drugs that are squeezing government programs like Medicare, employer-sponsored health plans, and individual consumers.”
AARP continues to fight to make prescription drugs more affordable for all Americans.
The organization supports federal legislation to allow the Food and Drug Administration to create a safe pathway for cost-effective generic biologics and advocates for removing barriers that delay the speedy introduction of lower costs generic drugs. AARP supports legislation that would allow Americans to safely and legally import lower priced prescription drugs from other countries, as well as promoting evidence-based research.
“These policies can help millions of Americans better afford their prescription drugs by increasing competition and putting downward pressure on prices,” concluded Rother. “Congress has options – now we need results.”
In Nevada, AARP has developed a brochure aimed at providing some very valuable information for Nevadans on prescription drug options they have available to help save dollars on Rx drugs as well as to better understand the medications they take.
“This publication has information on the prescription drug discount card program through the National Association of Counties, Nevada Senior Rx state prescription assistance program and other state-specific programs and services designed to help Nevadans with their prescription drugs,” said Barry Gold, director of government relations and advocacy for AARP’s Nevada Office.
For the complete Watchdog report visit: http://www.aarp.org/research/health/drugs/rx_watchdog.html.
To obtain a copy of Managing Your Medicine—Rx Drugs in Nevada, contact us with your name and mailing address at nvaarp@aarp.org or call 1-866-389-5652 and ask for the Nevada Publications Hotline.
AARP is a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole. AARP does not endorse candidates for public office or make contributions to either political campaigns or candidates. We produce AARP The Magazine, published bimonthly; AARP Bulletin, our monthly newspaper; AARP Segunda Juventud, our bimonthly magazine in Spanish and English; NRTA Live & Learn, our quarterly newsletter for 50+ educators; and our website, AARP.org. AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. We have staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.
30 – 30 – 30
There are no comments for this item.
journal Details
Added: Mar 11, 2008
Views: 652
Comments: 0
Bookmarks: 0
Views: 652
Comments: 0
Bookmarks: 0
Groups
No groups selected.
Tags
No tags selected.
